Investing Profile

Alexander Ehlgen

InvestorVC
Executive Director / Investment Manager - Boehringer Ingelheim Venture Fund at Boehringer Ingelheim Venture Fund
Photo of Alexander Ehlgen, Boehringer Ingelheim Venture Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Oxford Network
23 CONNECTIONS
University of Oxford Network
23 CONNECTIONS
HTGF | High-Tech Gründerfonds Network
22 CONNECTIONS
Boehringer Ingelheim Network
17 CONNECTIONS
Boehringer Ingelheim Network
17 CONNECTIONS
cb
$3.3M - $17.0M
$8.5M
3
CompanyStageDateRound SizeTotal Raised
Aignostics
Series BOct 2024$34M
SeedAug 2020$6M
$40M
C-mo Medical Solutions
SeedSep 2022$4M
$4M
Postdoctoral, Medical Vision Laboratory University of OxfordPresent
Department of Cardiology, John Radcliffe Hospital University of OxfordPresent
Senior Director Clinical Affairs POINT Biomedical CorporationPresent
Associate Medical Director, Global Clinical Development LantheusPresent
Medical Director, Discovery Medicine - Cardiovascular & Metabolism Bristol Myers SquibbPresent
Principal Translational Medicine Expert - Cardiovascular & Metabolism Boehringer IngelheimPresent
Head of Translational Medicine & Biomarker Experts Boehringer IngelheimPresent
Executive Director / Investment Manager - Boehringer Ingelheim Venture Fund Boehringer IngelheimPresent
Member, Board Of Directors AignosticsPresent
Member of the Investment Committee HTGF | High-Tech GründerfondsPresent
Member, Board Of Directors Tacalyx GmbHPresent
Member, Board of Directors C-mo Medical SolutionsPresent
Observer, Board of Directors ObulytixPresent
VP Early Investments RecordatiPresent
Observer, Board of Directors STRM.bioPresent
The University of Bonn Doctor of Medicine (M.D.) Medicine